Eine neue Ausgabe des Journals für ANTIMICROBIAL
Chemotherapy – / was für Fachleute…
Von:oupjournals-mailer@liontamer.stanford.edu
An:
Betreff: J. Antimicrob. Chemother. Table of Contents for June 2005; Vol. 55, No. 6
Datum: Thu, 9 Jun 2005 04:39:39 -0700
A new issue of Journal of Antimicrobial Chemotherapy
has been made available:
June 2005; Vol. 55, No. 6
URL: http://jac.oxfordjournals.org/content/vol55/issue6/index.dtl?etoc
—————————————————————–
Editorials
—————————————————————–
Reduced time to publication and increased rejection rate
C. W. E. Drummond and David S. Reeves
J. Antimicrob. Chemother. 2005 55: 815-816.
http://jac.oxfordjournals.org/cgi/content/full/55/6/815?etoc
—————————————————————–
Leading articles
—————————————————————–
Drug resistance and antiretroviral drug development
Robert W. Shafer and Jonathan M. Schapiro
J. Antimicrob. Chemother. 2005 55: 817-820.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/817?etoc
Switch strategies in patients on effective HAART
Franco Maggiolo, Diego Ripamonti, and Fredy Suter
J. Antimicrob. Chemother. 2005 55: 821-823.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/821?etoc
Role of viral kinetics under HCV therapy in HIV/HCV-coinfected patients
Angel Luis Ballesteros, Daniel Fuster, Ramon Planas, Bonaventura Clotet,
and Cristina Tural
J. Antimicrob. Chemother. 2005 55: 824-827.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/824?etoc
Lamivudine prophylaxis in HBV carriers with haemato-oncological
malignancies who receive chemotherapy
Ramazan Idilman
J. Antimicrob. Chemother. 2005 55: 828-831.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/828?etoc
—————————————————————–
Original articles
—————————————————————–
Genetic analysis of pbp2x in clinical Streptococcus pneumoniae isolates in
Quebec, Canada
Dominic Granger, Genevieve Boily-Larouche, Pierre Turgeon, Karl Weiss,
and Michel Roger
J. Antimicrob. Chemother. 2005 55: 832-839.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/832?etoc
Occurrence and molecular analysis of extended-spectrum
{beta}-lactamase-producing Proteus mirabilis in Hong Kong, 1999-2002
P. L. Ho, Alex Y. M. Ho, K. H. Chow, River C. W. Wong, R. S. Duan, W. L.
Ho, Gannon C. Mak, Kenneth W. Tsang, W. C. Yam, and K. Y. Yuen
J. Antimicrob. Chemother. 2005 55: 840-845.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/840?etoc
Increasing ceftriaxone resistance in Salmonella isolates from a university
hospital in Taiwan
Lin-Hui Su, Tsu-Lan Wu, Ju-Hsin Chia, Chishih Chu, An-Jing Kuo, and
Cheng-Hsun Chiu
J. Antimicrob. Chemother. 2005 55: 846-852.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/846?etoc
Brevundimonas diminuta infections and its resistance to fluoroquinolones
Xiang Y. Han and Roberto A. Andrade
J. Antimicrob. Chemother. 2005 55: 853-859.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/853?etoc
Direct detection in clinical samples of multiple gene mutations causing
resistance of Mycobacterium tuberculosis to isoniazid and rifampicin using
fluorogenic probes
Mateu Espasa, Julian Gonzalez-Martin, Fernando Alcaide, Lina Marcela
Aragon, Joan Lonca, Joxe Mari Manterola, Margarita Salvado, Griselda Tudo,
Pilar Orus, and Pere Coll
J. Antimicrob. Chemother. 2005 55: 860-865.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/860?etoc
Antibiotic susceptibilities of Legionella pneumophila strain Paris in
THP-1 cells as determined by real-time PCR assay
N. Roch and M. Maurin
J. Antimicrob. Chemother. 2005 55: 866-871.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/866?etoc
Limited development and progression of resistance of HIV-1 to the
nucleoside analogue reverse transcriptase inhibitor lamivudine in human
primary macrophages
Stefano Aquaro, Valentina Svicher, Francesca Ceccherini-Silberstein,
Alessandra Cenci, Fabbio Marcuccilli, Sara Giannella, Luisa Marcon,
Raffaele Calio, Jan Balzarini, and Carlo-Federico Perno
J. Antimicrob. Chemother. 2005 55: 872-878.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/872?etoc
Triclosan inhibition of fatty acid synthesis and its effect on growth of
Escherichia coli and Pseudomonas aeruginosa
Margarita Gomez Escalada, J. L. Harwood, J.-Y. Maillard, and D. Ochs
J. Antimicrob. Chemother. 2005 55: 879-882.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/879?etoc
In vitro antiplasmodial activity of prenylated chalcone derivatives of
hops (Humulus lupulus) and their interaction with haemin
Sonja Frolich, Carola Schubert, Ulrich Bienzle, and Kristina Jenett-Siems
J. Antimicrob. Chemother. 2005 55: 883-887.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/883?etoc
Susceptibilities of periodontopathogenic and cariogenic bacteria to
antibacterial peptides, {beta}-defensins and LL37, produced by human
epithelial cells
Kazuhisa Ouhara, Hitoshi Komatsuzawa, Sakuo Yamada, Hideki Shiba, Tamaki
Fujiwara, Masaru Ohara, Koji Sayama, Koji Hashimoto, Hidemi Kurihara, and
Motoyuki Sugai
J. Antimicrob. Chemother. 2005 55: 888-896.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/888?etoc
Activity of three {beta}-lactams (ertapenem, meropenem and ampicillin)
against intraphagocytic Listeria monocytogenes and Staphylococcus aureus
Sandrine Lemaire, Francoise Van Bambeke, Marie-Paule Mingeot-Leclercq,
and Paul M. Tulkens
J. Antimicrob. Chemother. 2005 55: 897-904.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/897?etoc
Squalene epoxidase encoded by ERG1 affects morphogenesis and drug
susceptibilities of Candida albicans
Ritu Pasrija, Shankarling Krishnamurthy, Tulika Prasad, Joachim F. Ernst,
and Rajendra Prasad
J. Antimicrob. Chemother. 2005 55: 905-913.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/905?etoc
A comparative study of fungicidal activities of voriconazole and
amphotericin B against hyphae of Aspergillus fumigatus
Suganthini Krishnan, Elias K. Manavathu, and Pranatharthi H. Chandrasekar
J. Antimicrob. Chemother. 2005 55: 914-920.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/914?etoc
Phenotypic variability of Pseudomonas aeruginosa in sputa from patients
with acute infective exacerbation of cystic fibrosis and its impact on the
validity of antimicrobial susceptibility testing
J. E. Foweraker, C. R. Laughton, D. F. J. Brown, and D. Bilton
J. Antimicrob. Chemother. 2005 55: 921-927.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/921?etoc
Diversity among 2481 Escherichia coli from women with community-acquired
lower urinary tract infections in 17 countries
M. Landgren, H. Oden, I. Kuhn, A. Osterlund, and G. Kahlmeter
J. Antimicrob. Chemother. 2005 55: 928-937.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/928?etoc
Mutant prevention concentrations of ciprofloxacin for urinary tract
infection isolates of Escherichia coli
Linda L. Marcusson, Sara K. Olofsson, Patricia Komp Lindgren, Otto Cars,
and Diarmaid Hughes
J. Antimicrob. Chemother. 2005 55: 938-943.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/938?etoc
Comparative in vitro antimicrobial activity of a new carbapenem,
doripenem: tentative disc diffusion criteria and quality control
Steven D. Brown and Maria M. Traczewski
J. Antimicrob. Chemother. 2005 55: 944-949.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/944?etoc
In vitro activity of linezolid, clarithromycin and moxifloxacin against
clinical isolates of Mycobacterium kansasii
Remedios Guna, Carlos Munoz, Victoria Dominguez, Angeles Garcia-Garcia,
Jorge Galvez, Jesus-Vicente de Julian-Ortiz, and Rafael Borras
J. Antimicrob. Chemother. 2005 55: 950-953.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/950?etoc
Citywide emergence of Pseudomonas aeruginosa strains with reduced
susceptibility to polymyxin B
David Landman, Simona Bratu, Maqsood Alam, and John Quale
J. Antimicrob. Chemother. 2005 55: 954-957.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/954?etoc
Antimicrobial susceptibility and serotype distribution of Streptococcus
pneumoniae causing meningitis in Egypt, 1998-2003
Momtaz O. Wasfy, Guillermo Pimentel, Mohammed Abdel-Maksoud, Kevin L.
Russell, Christopher P. Barrozo, John D. Klena, Kenneth Earhart, and Rana
Hajjeh
J. Antimicrob. Chemother. 2005 55: 958-964.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/958?etoc
In vitro susceptibilities of aerobic and facultative Gram-negative bacilli
isolated from patients with intra-abdominal infections worldwide: the 2003
Study for Monitoring Antimicrobial Resistance Trends (SMART)
David L. Paterson, Flavia Rossi, Fernando Baquero, Po-Ren Hsueh, Gail L.
Woods, Vilas Satishchandran, Theresa A. Snyder, Charlotte M. Harvey, Hedy
Teppler, Mark J. DiNubile, and Joseph W. Chow
J. Antimicrob. Chemother. 2005 55: 965-973.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/965?etoc
Effects of piperacillin/tazobactam on Clostridium difficile growth and
toxin production in a human gut model
Simon D. Baines, Jane Freeman, and Mark H. Wilcox
J. Antimicrob. Chemother. 2005 55: 974-982.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/974?etoc
Antisense phosphorodiamidate morpholino oligomer inhibits viability of
Escherichia coli in pure culture and in mouse peritonitis
Bruce L. Geller, Jesse Deere, Lucas Tilley, and Patrick L. Iversen
J. Antimicrob. Chemother. 2005 55: 983-988.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/983?etoc
A new approach for treatment of deep skin infections by an ethosomal
antibiotic preparation: an in vivo study
B. Godin, E. Touitou, E. Rubinstein, A. Athamna, and M. Athamna
J. Antimicrob. Chemother. 2005 55: 989-994.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/989?etoc
Comparative evaluation of tigecycline and vancomycin, with and without
rifampicin, in the treatment of methicillin-resistant Staphylococcus
aureus experimental osteomyelitis in a rabbit model
Li-Yan Yin, Luca Lazzarini, Fan Li, C. Melinda Stevens, and Jason H.
Calhoun
J. Antimicrob. Chemother. 2005 55: 995-1002.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/995?etoc
Use of lopinavir/ritonavir in HIV-infected patients failing a first-line
protease-inhibitor-containing HAART
Marco Bongiovanni, Elisabetta Chiesa, Antonio Di Biagio, Paola Meraviglia,
Amedeo Capetti, Federica Tordato, Paola Cicconi, Patrizia Biasi, Teresa
Bini, and Antonella d’Arminio Monforte
J. Antimicrob. Chemother. 2005 55: 1003-1007.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/1003?etoc
Successful oral pristinamycin therapy for osteoarticular infections due to
methicillin-resistant Staphylococcus aureus (MRSA) and other
Staphylococcus spp.
John Ng and Iain B. Gosbell
J. Antimicrob. Chemother. 2005 55: 1008-1012.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/1008?etoc
—————————————————————–
Brief reports
—————————————————————–
Propyl paraben induces potassium efflux in Escherichia coli
Jerome Bredin, Anne Davin-Regli, and Jean-Marie Pages
J. Antimicrob. Chemother. 2005 55: 1013-1015.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/1013?etoc
Effect of media composition and in vitro activity of posaconazole,
caspofungin and voriconazole against zygomycetes
Cristina Gil-Lamaignere, Regina Hess, Stefanie Salvenmoser, Kathrin Heyn,
Reinhard Kappe, and Frank-Michael C. Muller
J. Antimicrob. Chemother. 2005 55: 1016-1019.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/1016?etoc
In vitro interaction of micafungin with conventional and new antifungals
against clinical isolates of Trichosporon, Sporobolomyces and Rhodotorula
Carolina Serena, Marcal Marine, F. Javier Pastor, Nicole Nolard, and
Josep Guarro
J. Antimicrob. Chemother. 2005 55: 1020-1023.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/1020?etoc
Evaluation of the in vitro activity of NVP-LMB415 against clinical
anaerobic isolates with emphasis on the Bacteroides fragilis group
David R. Snydman, Nilda V. Jacobus, and Laura A. McDermott
J. Antimicrob. Chemother. 2005 55: 1024-1028.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/1024?etoc
Trimethoprim/sulfamethoxazole resistance in clinical isolates of
Burkholderia pseudomallei
Vanaporn Wuthiekanun, Allen C. Cheng, Wirongrong Chierakul, Premjit
Amornchai, Direk Limmathurotsakul, Wipada Chaowagul, Andrew J. H. Simpson,
Jennifer M. Short, Gumphol Wongsuvan, Bina Maharjan, Nicholas J. White,
and Sharon J. Peacock
J. Antimicrob. Chemother. 2005 55: 1029-1031.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/1029?etoc
Gentamicin-loaded microspheres for treatment of experimental Brucella
abortus infection in mice
Sandra Prior, Bruno Gander, Juan M. Irache, and Carlos Gamazo
J. Antimicrob. Chemother. 2005 55: 1032-1036.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/1032?etoc
A 6 week course of azithromycin treatment has no beneficial effect on
atherosclerotic lesion development in apolipoprotein E-deficient mice
chronically infected with Chlamydia pneumoniae
E. Blessing, L. A. Campbell, M. E. Rosenfeld, B. Chesebro, and C.-C. Kuo
J. Antimicrob. Chemother. 2005 55: 1037-1040.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/1037?etoc
Low-doses of indinavir boosted with ritonavir in HIV-infected Thai
patients: pharmacokinetics, efficacy and tolerability
Tim R. Cressey, Prattana Leenasirimakul, Gonzague Jourdain, Michel Tod,
Pra-ornsuda Sukrakanchana, Suparat Kunkeaw, Chutima Puttimit, and Marc
Lallemant
J. Antimicrob. Chemother. 2005 55: 1041-1044.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/1041?etoc
Trends in antibiotic prescribing for acute respiratory infection in
veterans with spinal cord injury and disorder
Charlesnika T. Evans, Bridget Smith, Jorge P. Parada, Jibby E. Kurichi,
and Frances M. Weaver
J. Antimicrob. Chemother. 2005 55: 1045-1049.
http://jac.oxfordjournals.org/cgi/content/abstract/55/6/1045?etoc
—————————————————————–
Correspondence
—————————————————————–
Revised Ambler classification of {beta}-lactamases
Barry G. Hall and Miriam Barlow
J. Antimicrob. Chemother. 2005 55: 1050-1051.
http://jac.oxfordjournals.org/cgi/content/full/55/6/1050?etoc
Is it necessary to change the classification of {beta}-lactamases?
Jean-Marie Frere, Moreno Galleni, Karen Bush, and Otto Dideberg
J. Antimicrob. Chemother. 2005 55: 1051-1053.
http://jac.oxfordjournals.org/cgi/content/full/55/6/1051?etoc
New aac(6′)-I genes in Enterococcus hirae and Enterococcus durans: effect
on {beta}-lactam/aminoglycoside synergy
Rosa del Campo, Juan Carlos Galan, Carmen Tenorio, Patricia
Ruiz-Garbajosa, Myriam Zarazaga, Carmen Torres, and Fernando Baquero
J. Antimicrob. Chemother. 2005 55: 1053-1055.
http://jac.oxfordjournals.org/cgi/content/full/55/6/1053?etoc
Heteroresistance to carbapenems in Acinetobacter baumannii
S. Pournaras, A. Ikonomidis, A. Markogiannakis, A. N. Maniatis, and A.
Tsakris
J. Antimicrob. Chemother. 2005 55: 1055-1056.
http://jac.oxfordjournals.org/cgi/content/full/55/6/1055?etoc
—————————————————————–
Errata
—————————————————————–
Antimicrobial susceptibility of bifidobacteria
C. Moubareck, F. Gavini, L. Vaugien, M. J. Butel, and F. Doucet-Populaire
J. Antimicrob. Chemother. 2005 55: 1057.
http://jac.oxfordjournals.org/cgi/content/full/55/6/1057?etoc
http://jac.oxfordjournals.org/subscriptions/etoc.dtl
Or by mail:
Customer Service * 1454 Page Mill Road * Palo Alto, CA 94304 * U.S.A.
_______________________________________________________________________
Copyright (c) 2005 by the The British Society for Antimicrobial
Chemotherapy.